Journals / Türk Hijyen ve Deneysel Biyoloji Dergisi / 2021 / Cilt: 78 - Sayı: 2

The possible role of Kallikrein-6, 7, and potassium channel proteins in Alzheimer’s disease

Alzheimer hastalığında Kallikrein-6, 7 ve potasyum kanal proteinlerinin olası rolü

Pages
125–132
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to the findings of the present study, a positive correlation was detected between the levels of KLK-6 and KLK-7 and AD’s pathology.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Although the formation mechanism of Alzheimer’s Disease (AD) is not known with certainty, two major proteins, beta amyloid of senile plaques and tau protein of neurofibrillary tangels are responsible for AD.
📊
Key Findings & Data:One of the major factors in the development of the disease is the formation of in soluble amyloid deposits, and the other one is the increased tau phosphorylation.
💡
Conclusion & Impact:According to the findings of the present study, a positive correlation was detected between the levels of KLK-6 and KLK-7 and AD’s pathology.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Although the formation mechanism of Alzheimer’s Disease (AD) is not known with certainty, two major proteins, beta amyloid of senile plaques and tau protein of neurofibrillary tangels are responsible for AD. One of the major factors in the development of the disease is the formation of in soluble amyloid deposits, and the other one is the increased tau phosphorylation. Kallikreins (KLK’s) are a sub-family of serine proteases that play a role in the etiology of AD which is characterized by neuronal damage and loss of function.Kallikrein (KLK)-6 and KLK-7 are known to be age-related protease and are found at high levels in the central nervous system (CNS). It was previously shown to be involved in proteolysis of extracellular proteins implicated in neurodegenerative diseases such as AD. In this study, we aimed to investigate the possible role of KLK-6 and KLK-7 in the pathogenesis of AD and the relationship between potassium channel proteins. Methods: A total of 35 Alzheimer’s patients over the age 65 years, followed-up by Polatlı Duatepe Government Hospital and 35 healthy individuals (control group) admitted to the neurology clinic for routine screening with cognitive status considered normal were included in this study. After a 12-hour hunger, KLK-6 and KLK-7 were measured with inwardly rectifying potassium channel protein (KCNJ3), and two-pore potassium channel protein (KCNK9) levels were measured by the Enzyme-Linked Immuno Sorbent Assay (ELISA) in the serum of the blood samples which were taken from the antecubital vein after centrifuging for 10 minutes at 2500xg. The differences between the two groups were tested by T- test. A value of p0.05). According to our findings, serum KLK- 6 and KLK-7 levels of Alzheimer’s group were significantly increased (p0.05). Conclusion: It is thought that the failure in preventing the abnormal protein folding and accumulation leads to AD in the brain. According to the findings of the present study, a positive correlation was detected between the levels of KLK-6 and KLK-7 and AD’s pathology.

Özet

Amaç: Alzheimer hastalığının (AH) oluşum mekanizması kesin olarak bilinmemekle birlikte AH’dan sorumlu başlıca iki protein, senile plakların yapısındaki beta amiloid ve nörofibriler yumakların yapısındaki tau proteinidir. Hastalığa yol açan en önemli etmenlerden biri çözünür olmayan amiloid çökeltilerin oluşumu, diğeri ise artmış tau fosforillenmesidir. Kallikreinler, nöronal hasar ve işlev kaybı ile belirgin AH’nın etiyolojisinde rol oynayan, serin proteazların bir alt familyasıdır. Kallikrein (KLK)-6 ve KLK-7’nin merkezi sinir sisteminde (MSS) yüksek seviyelerde bulunan yaşa bağlı proteaz olduğu bilinmektedir. Daha once AH’ı gibi nörodejeneratif hastalıklarda yer alan hücre dışı proteinlerin proteolizine karıştığı gösterilmiştir. Bu çalışmada KLK-6 ve KLK-7’nin AH patogenezindeki olası rolünü ve potasyum kanal proteinleri arasındaki ilişkiyi araştırmayı amaçladık. Yöntem: Çalışmaya Polatlı Duatepe Devlet Hastanesinde takip edilen yaşları 65’in üzerinde olan 35 AH ve rutin tarama amacıyla nöroloji polikliniğine başvuran kognitif durumu normal olarak değerlendirilen 35 sağlıklı birey (control grubu) dahil edildi. 12 saat açlığı takiben antekübital venden alınan kan örnekleri 4°C’de 2500xg’de 10 dakika santrifüj edilerek, serum örneklerinde KLK-6 ve KLK-7 ile içeri doğru düzeltici potasyum kanalı (KCNJ3) ve iki gözenekli potasyum kanalı (KCNK9) protein düzeyleri enzim-bağımlı immunosorbent assay (ELISA) ile ölçüldü. Gruplar arasındaki fark T-test ile incelendi. p0.05). Alzheimer grubu control grubu ile karşılaştırıldığında serum KLK-6 ve KLK-7 düzeyleri anlamlı olarak artarken (p0.05). Sonuç: Beyinde anormal protein katlanmasının ve birikmesinin önüne geçilememesinin AH’ye yol açtığı düşünülmektedir. Bu araştırmanın bulgularına göre KLK- 6 ve KLK-7 düzeyleri ile AH’nın patolojisi arasında bir ilişki saptandı.

🔖

Cite This Article

BULDUK, E. B., YILDIRIM, Z., YILDIRIM, F. (2022). The possible role of Kallikrein-6, 7, and potassium channel proteins in Alzheimer’s disease. Türk Hijyen ve Deneysel Biyoloji Dergisi, Cilt: 78 - Sayı: 2, 125–132. https://ajindex.com/articles/624959

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Holtzman DM, Goate A, Kelly J, Sperling R. Mapping the road forward in Alzheimer’s disease. Sci Transl Med, 2011; 3 (114): 114-48
  2. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer’s disease. Lancet, 2011; 377 (9770): 1019-31
  3. Sotiropoulou G, Pampalakis G, Diamandis EP. Functional roles of human kallikrein-related peptidases. J Biol Chem, 2009; 284 (48): 32989-94
  4. Parassas I, Elssa A, Poda G, Diamandis EP. Unleashing the therapeutic otential of human kallikreinrelated serine proteases. Na 5. Borgono CA, Michael IP, Diamandis EP. Human tissue kallikreins: Physiologic roles and applications in cancer. Molecular Cancer Research, 2004; 2(5): 257-80
  5. Aronson JK. Potassium channels in nervous tissue. Biochem Pharmacology, 1992; 43 (1): 11-4
  6. Pongs O. Voltage-gatedpotassium channels: from hyperexcitability to excitement. FEBS Letters, 1999; 452 (1-2): 31-5
  7. Bronstein-Sitton S. K+ channels and cancer. Pathways, 2006; 12 (1): 18-20
  8. Kaneko S, Okada M, Iwasa H, Yamakawa K, Hirose S. Genetics of epilepsy: current status and perspectives. Neurosci Res, 2002; 44 (1): 11-30
  9. Marban E. Cardiac channelopathies. Nature, 2002; 415 (3): 213-18
  10. Jurkat- Rott K, LercheH, Lehmann-Horn F. Skeletal muscle channelopathies. J Neurol, 2002; 249 (1): 1493-1502
  11. Nichols CG, Koster JC. Diabetes and insulin secretion: whither KATP? Am J Physiol Endocrinol Metab, 2002; 283 (3): E403-12
  12. Olesen SP, Bundgaard M. ATP-dependent closure and reactivation of inward rectifier K+ channels in endothelial cells. Circ Res, 1993; 73 (3): 492-95
  13. Bayliss DA, Sirois JE, Talley EM. The TASK family: two-pore domain background K+ channels. Mol Interv, 2003; 3 (5): 205-19
  14. Lauritzen I, Zanzouri M, Honore E, Duprat F, Ehrengruber MU, Lazdunski M, et al. K+ dependent cerebellar granule neuron apoptosis. Role of task leak K+ channels. J Biol Chem, 2003; 278 (34): 32068-76
  15. Yildirim Z, Ucgun NI, Yildirim F. The role of oxidative stress and antioxidants in the pathogenesis of agerelated macular degeneration. Clinics (Sao Paulo), 2011; 66(5): 743-46
  16. Yildirim Z, Yildirim F, Ucgun NI, Dincel AS. Choroidal Neovascular Membrane in Age-Related Macular Degeneration is Associated with Increased Interleukin-6. International J Gerontology, 2012; 6(2): 101-4
  17. Gandhi S, Abramov AY. Mechanism of oxidative stress in neurodegeneration. Oxid Med Cell Longev, 2012; 2012: 1-11
  18. Sutherland GT, Chami B, Youssef P, Witting PK. Oxidative stress